Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

John Morris

Showing results (251-260 of 274) with videos related to

Pageof 28
Sort By:
Network Neuroscience (Cambridge, Mass.)|December 30, 2024
Increasing hub disruption parallels dementia severity in autosomal dominant Alzheimer's diseaseJiaxin Cindy Tu, Peter R Millar, Jeremy F Strain, et al.
Neuroimage|December 11, 2019
Harmonization of large MRI datasets for the analysis of brain imaging patterns throughout the lifespanRaymond Pomponio, Guray Erus, Mohamad Habes, et al.
Brain : a Journal of Neurology|June 28, 2020
MRI signatures of brain age and disease over the lifespan based on a deep brain network and 14 468 individuals worldwideVishnu M Bashyam, Guray Erus, Jimit Doshi, et al.
Research Square|April 1, 2025
Large-scale Plasma Proteomic Profiling Unveils Novel Diagnostic Biomarkers and Pathways for Alzheimer's DiseaseCarlos Cruchaga, Gyujin Heo, Alvin Thomas, et al.
Research Square|August 7, 2024
Ubiquitin-Proteasome System in the Different Stages of Dominantly Inherited Alzheimer's DiseaseEric McDade, Haiyan Liu, Quoc Bui, et al.
The Lancet. Gastroenterology & Hepatology|April 14, 2017
Mercaptopurine versus placebo to prevent recurrence of Crohn's disease after surgical resection (TOPPIC): a multicentre, double-blind, randomised controlled trialCraig Mowat, Ian Arnott, Aiden Cahill, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|October 16, 2012
The advantages of frontotemporal degeneration drug development (part 2 of frontotemporal degeneration: the next therapeutic frontier)Adam L Boxer, Michael Gold, Edward Huey, et al.
Nature Biotechnology|June 8, 2017
The promise of organ and tissue preservation to transform medicineSebastian Giwa, Jedediah K Lewis, Luis Alvarez, et al.
Medrxiv : the Preprint Server for Health Sciences|August 16, 2024
15 Years of Longitudinal Genetic, Clinical, Cognitive, Imaging, and Biochemical Measures in DIANAlisha J Daniels, Eric McDade, Jorge J Llibre-Guerra, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|January 19, 2026
Brain volume trajectories in Down syndrome and autosomal dominant Alzheimer's diseaseJames T Kennedy, Julie K Wisch, Anna H Boerwinkle, et al.
Pageof 28

Showing results (251-260 of 274) with videos related to

Sort By:
Pageof 28
Network Neuroscience (Cambridge, Mass.)|December 30, 2024
Increasing hub disruption parallels dementia severity in autosomal dominant Alzheimer's diseaseJiaxin Cindy Tu, Peter R Millar, Jeremy F Strain, et al.
Neuroimage|December 11, 2019
Harmonization of large MRI datasets for the analysis of brain imaging patterns throughout the lifespanRaymond Pomponio, Guray Erus, Mohamad Habes, et al.
Brain : a Journal of Neurology|June 28, 2020
MRI signatures of brain age and disease over the lifespan based on a deep brain network and 14 468 individuals worldwideVishnu M Bashyam, Guray Erus, Jimit Doshi, et al.
Research Square|April 1, 2025
Large-scale Plasma Proteomic Profiling Unveils Novel Diagnostic Biomarkers and Pathways for Alzheimer's DiseaseCarlos Cruchaga, Gyujin Heo, Alvin Thomas, et al.
Research Square|August 7, 2024
Ubiquitin-Proteasome System in the Different Stages of Dominantly Inherited Alzheimer's DiseaseEric McDade, Haiyan Liu, Quoc Bui, et al.
The Lancet. Gastroenterology & Hepatology|April 14, 2017
Mercaptopurine versus placebo to prevent recurrence of Crohn's disease after surgical resection (TOPPIC): a multicentre, double-blind, randomised controlled trialCraig Mowat, Ian Arnott, Aiden Cahill, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|October 16, 2012
The advantages of frontotemporal degeneration drug development (part 2 of frontotemporal degeneration: the next therapeutic frontier)Adam L Boxer, Michael Gold, Edward Huey, et al.
Nature Biotechnology|June 8, 2017
The promise of organ and tissue preservation to transform medicineSebastian Giwa, Jedediah K Lewis, Luis Alvarez, et al.
Medrxiv : the Preprint Server for Health Sciences|August 16, 2024
15 Years of Longitudinal Genetic, Clinical, Cognitive, Imaging, and Biochemical Measures in DIANAlisha J Daniels, Eric McDade, Jorge J Llibre-Guerra, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|January 19, 2026
Brain volume trajectories in Down syndrome and autosomal dominant Alzheimer's diseaseJames T Kennedy, Julie K Wisch, Anna H Boerwinkle, et al.
Pageof 28